Ahmad, Nur-aiza A.

HRN: 11-54-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/19/2025
06/26/2025
IV
500mg
Q8
T/c Acute Appendicitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: